GSDMD and Sepsis: Besides interleukins, GSDMD pores mediate the release of extracellular cold‐inducible RNA binding protein (eCIRP) from living macrophages, suggesting that targeting GSDMD could be a novel and potential therapeutic approach to inhibit eCIRP‐mediated inflammation in sepsis [108].